Nurix Therapeutics, Inc. (NRIX)
26.03
+0.25
(+0.97%)
USD |
NASDAQ |
Sep 01, 16:00
26.03
0.00 (0.00%)
After-Hours: 17:26
Nurix Therapeutics Total Long Term Debt (Quarterly) : 54.92M for May 31, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 54.92M |
| February 28, 2026 | 55.45M |
| November 30, 2025 | 52.91M |
| August 31, 2025 | 52.70M |
| May 31, 2025 | 46.70M |
| February 28, 2025 | 19.98M |
| November 30, 2024 | 20.29M |
| August 31, 2024 | 20.59M |
| May 31, 2024 | 20.88M |
| February 29, 2024 | 21.85M |
| November 30, 2023 | 23.12M |
| August 31, 2023 | 2.642M |
| May 31, 2023 | 3.758M |
| February 28, 2023 | 5.106M |
| November 30, 2022 | 6.434M |
| Date | Value |
|---|---|
| August 31, 2022 | 7.745M |
| May 31, 2022 | 9.043M |
| February 28, 2022 | 10.33M |
| November 30, 2021 | 9.189M |
| August 31, 2021 | 0.00 |
| May 31, 2021 | 0.00 |
| February 28, 2021 | 0.00 |
| November 30, 2020 | 0.00 |
| August 31, 2020 | 0.00 |
| May 31, 2020 | 168.11M |
| February 29, 2020 | 48.20M |
| November 30, 2019 | 0.00 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Monte Rosa Therapeutics, Inc. | 33.36M |
| Gilead Sciences, Inc. | 26.25B |
| TG Therapeutics, Inc. | 752.53M |
| Cue Biopharma, Inc. | 7.179M |
| Keros Therapeutics, Inc. | 13.13M |